首页> 外文OA文献 >PSS30 Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

【2h】

PSS30 Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

机译：PSS30在荷兰与年龄相关的湿性黄斑变性（Wamd）治疗的成本效益，玻璃体内阿柏西普（Ivt-Afl）和雷珠单抗的案例

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Tempelaar S; Stephens S; Schouten J;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost comparison of intravitreal aflibercept with bevacizumab and ranibizumab for the treatment of wet age-related macular degeneration [J] . Ophthalmic surgery, lasers & imaging retina . 2015,第1期

机译：玻璃体内阿柏西普联合贝伐单抗和兰尼单抗治疗湿性年龄相关性黄斑变性的成本比较
2. Aflibercept vs. Ranibizumab: cost-effectiveness of treatment for wet age-related macular degeneration in Sweden [J] . Panchmatia Hemangi R., Clements Karen M., Hulbert Erin, Acta ophthalmologica . 2016,第5期

机译：Aflibercept与Ranibizumab：在瑞典治疗与年龄相关的湿性黄斑变性的成本效益
3. Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab [J] . Daniel Sanju Narayan, James Muecke Indian Journal of Ophthalmology . 2015,第11期

机译：玻璃体腔内使用abriberceptcept预先接受玻璃体腔雷珠单抗治疗后，出现渗出性年龄相关性黄斑变性的眼睛
4. Expression Pattern of Kinin-Dependent Genes in Peripheral Blood Mononuclear Cells After Age-Related Macular Degeneration Treatment with Ranibizumab [C] . Michalska-Malecka K, Strzalka-Mrozik B., Kimsa M.W., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：与RANIBIZIMAB的年龄相关黄斑治疗后外周血单核细胞在外周血单核细胞中的表达模式
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. Real Life Data of Treat and Extend Intravitreal Ranibizumab and Aflibercept Therapy in Wet Age-related Macular Degeneration Patients: 3-Year Results [O] . Ozgul Ugurtay, Alev Kockar, Elvan Alper Sengul 2021

机译：治疗和扩展术治疗湿性年龄相关性黄斑患者的术治疗和术治疗的现实生活数据：3年结果
7. PSS3 Cost-Effectiveness Analysis of Intravitreal Aflibercept Compared with Ranibizumab-Prn in Patients with wet Age-Related Macular Degeneration (Wamd) [O] . Murra Anton ZA 2015

机译：与湿性年龄相关性黄斑变性（Wamd）患者相比，玻璃体内阿柏西普与雷珠单抗-Prn的PSS3成本-效果分析

PSS30 Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

著录项

相似文献

相关主题

期刊订阅